{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:10:20Z","timestamp":1780521020309,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Norn Group","award":["AWD-007726"],"award-info":[{"award-number":["AWD-007726"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-024-01221-0","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T23:02:00Z","timestamp":1717628520000},"page":"4135-4146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of off-label rapamycin use on oral health"],"prefix":"10.1007","volume":"46","author":[{"given":"Johnny","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammi","family":"Kaeberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akashdeep","family":"Mahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Ghorbanifarajzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Radella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anar","family":"Isman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Nyquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Zalzala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-3421","authenticated-orcid":false,"given":"Matt","family":"Kaeberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-8608","authenticated-orcid":false,"given":"Jonathan Y.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"1221_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"BK Kennedy","year":"2014","unstructured":"Kennedy BK, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709\u201313. https:\/\/doi.org\/10.1016\/j.cell.2014.10.039.","journal-title":"Cell"},{"key":"1221_CR2","doi-asserted-by":"publisher","first-page":"025163","DOI":"10.1101\/cshperspect.a025163","volume":"6","author":"F Sierra","year":"2016","unstructured":"Sierra F. The emergence of geroscience as an interdisciplinary approach to the enhancement of health span and life span. Cold Spring Harb Perspect Med. 2016;6:025163. https:\/\/doi.org\/10.1101\/cshperspect.a025163.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1221_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-016-9954-6","volume":"39","author":"F Sierra","year":"2017","unstructured":"Sierra F, Kohanski R. Geroscience and the trans-NIH Geroscience Interest Group, GSIG. Geroscience. 2017;39:1\u20135. https:\/\/doi.org\/10.1007\/s11357-016-9954-6.","journal-title":"Geroscience"},{"key":"1221_CR4","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194\u2013217. https:\/\/doi.org\/10.1016\/j.cell.2013.05.039.","journal-title":"Cell"},{"key":"1221_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/gerona\/glq178","volume":"66","author":"RA Miller","year":"2011","unstructured":"Miller RA, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. The journals of gerontology. Series A, Biol Sci Med Sci. 2011;66:191\u2013201. https:\/\/doi.org\/10.1093\/gerona\/glq178.","journal-title":"Series A, Biol Sci Med Sci"},{"key":"1221_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/acel.12194","volume":"13","author":"RA Miller","year":"2014","unstructured":"Miller RA, et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014;13:468\u201377. https:\/\/doi.org\/10.1111\/acel.12194.","journal-title":"Aging Cell"},{"key":"1221_CR7","doi-asserted-by":"publisher","unstructured":"A. Bitto et al. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife 5, (2016).https:\/\/doi.org\/10.7554\/eLife.16351","DOI":"10.7554\/eLife.16351"},{"key":"1221_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/acel.12617","volume":"16","author":"X Dou","year":"2017","unstructured":"Dou X, et al. Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice. Aging Cell. 2017;16:825\u201336. https:\/\/doi.org\/10.1111\/acel.12617.","journal-title":"Aging Cell"},{"key":"1221_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11357-017-9972-z","volume":"39","author":"SR Urfer","year":"2017","unstructured":"Urfer SR, et al. A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs. Geroscience. 2017;39:117\u201327. https:\/\/doi.org\/10.1007\/s11357-017-9972-z.","journal-title":"Geroscience"},{"key":"1221_CR10","doi-asserted-by":"publisher","unstructured":"E. Quarles et al. Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment. Aging Cell. 2019; e13086.https:\/\/doi.org\/10.1111\/acel.13086","DOI":"10.1111\/acel.13086"},{"key":"1221_CR11","doi-asserted-by":"publisher","unstructured":"J. Y. An et al. Rapamycin rejuvenates oral health in aging mice. Elife. 2020;9.https:\/\/doi.org\/10.7554\/eLife.54318","DOI":"10.7554\/eLife.54318"},{"key":"1221_CR12","doi-asserted-by":"publisher","unstructured":"G. Aiello et al. Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster. EMBO Rep. 2022; e55299.https:\/\/doi.org\/10.15252\/embr.202255299","DOI":"10.15252\/embr.202255299"},{"key":"1221_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/odi.12051","volume":"19","author":"O Pereira-Lopes","year":"2013","unstructured":"Pereira-Lopes O, et al. Periodontal inflammation in renal transplant recipients receiving everolimus or tacrolimus - preliminary results. Oral Dis. 2013;19:666\u201372. https:\/\/doi.org\/10.1111\/odi.12051.","journal-title":"Oral Dis"},{"key":"1221_CR14","doi-asserted-by":"publisher","unstructured":"J. B. Mannick et al. mTOR inhibition improves immune function in the elderly. Science Translational Medicine. 2014;6:268ra179--268ra179.https:\/\/doi.org\/10.1126\/scitranslmed.3009892","DOI":"10.1126\/scitranslmed.3009892"},{"key":"1221_CR15","doi-asserted-by":"publisher","unstructured":"J. B. Mannick et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018;10. https:\/\/doi.org\/10.1126\/scitranslmed.aaq1564","DOI":"10.1126\/scitranslmed.aaq1564"},{"key":"1221_CR16","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/med.21773","volume":"41","author":"A Vaiserman","year":"2021","unstructured":"Vaiserman A, Koliada A, Lushchak O, Castillo MJ. Repurposing drugs to fight aging: the difficult path from bench to bedside. Med Res Rev. 2021;41:1676\u2013700. https:\/\/doi.org\/10.1002\/med.21773.","journal-title":"Med Res Rev"},{"key":"1221_CR17","doi-asserted-by":"publisher","first-page":"e13596","DOI":"10.1111\/acel.13596","volume":"21","author":"AS Kulkarni","year":"2022","unstructured":"Kulkarni AS, et al. Geroscience-guided repurposing of FDA-approved drugs to target aging: a proposed process and prioritization. Aging Cell. 2022;21:e13596. https:\/\/doi.org\/10.1111\/acel.13596.","journal-title":"Aging Cell"},{"key":"1221_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2017.12.026","volume":"105","author":"E Kraig","year":"2018","unstructured":"Kraig E, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: immunological, physical performance, and cognitive effects. Exp Gerontol. 2018;105:53\u201369. https:\/\/doi.org\/10.1016\/j.exger.2017.12.026.","journal-title":"Exp Gerontol"},{"key":"1221_CR19","doi-asserted-by":"publisher","unstructured":"T. L. Kaeberlein et al. Evaluation of off-label rapamycin use to promote healthspan in 333 adults. Geroscience. 2023;1\u201312.https:\/\/doi.org\/10.1007\/s11357-023-00818-1","DOI":"10.1007\/s11357-023-00818-1"},{"key":"1221_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-017-9994-6","author":"JY An","year":"2017","unstructured":"An JY, et al. Rapamycin treatment attenuates age-associated periodontitis in mice. Geroscience. 2017. https:\/\/doi.org\/10.1007\/s11357-017-9994-6.","journal-title":"Geroscience"},{"key":"1221_CR21","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.3892\/mmr.2017.7693","volume":"16","author":"X Li","year":"2017","unstructured":"Li X, et al. Rapamycin promotes osteogenesis under inflammatory conditions. Mol Med Rep. 2017;16:8923\u20139. https:\/\/doi.org\/10.3892\/mmr.2017.7693.","journal-title":"Mol Med Rep"},{"key":"1221_CR22","doi-asserted-by":"publisher","first-page":"20739","DOI":"10.1021\/acsomega.3c01289","volume":"8","author":"C Feng","year":"2023","unstructured":"Feng C, et al. Rapamycin inhibits osteoclastogenesis and prevents LPS-induced alveolar bone loss by oxidative stress suppression. ACS Omega. 2023;8:20739\u201354. https:\/\/doi.org\/10.1021\/acsomega.3c01289.","journal-title":"ACS Omega"},{"key":"1221_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14336\/AD.2022.0623","volume":"14","author":"R Elsayed","year":"2023","unstructured":"Elsayed R, et al. Microbially-induced exosomes from dendritic cells promote paracrine immune senescence: novel mechanism of bone degenerative disease in mice. Aging Dis. 2023;14:136\u201351. https:\/\/doi.org\/10.14336\/AD.2022.0623.","journal-title":"Aging Dis"},{"issue":"Suppl 20","key":"1221_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/jcpe.12935","volume":"45","author":"JG Caton","year":"2018","unstructured":"Caton JG, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45(Suppl 20):S1\u20138. https:\/\/doi.org\/10.1111\/jcpe.12935.","journal-title":"J Clin Periodontol"},{"issue":"Suppl 1","key":"1221_CR25","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1002\/JPER.17-0719","volume":"89","author":"ILC Chapple","year":"2018","unstructured":"Chapple ILC, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89(Suppl 1):S74\u201384. https:\/\/doi.org\/10.1002\/JPER.17-0719.","journal-title":"J Periodontol"},{"key":"1221_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrmicro2337","volume":"8","author":"RP Darveau","year":"2010","unstructured":"Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8:481\u201390. https:\/\/doi.org\/10.1038\/nrmicro2337.","journal-title":"Nat Rev Microbiol"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01221-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-024-01221-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01221-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T08:25:33Z","timestamp":1724315133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-024-01221-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["1221"],"URL":"https:\/\/doi.org\/10.1007\/s11357-024-01221-0","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MK is a co-founder of the Optispan Geroscience, which has no material interest in rapamycin or rapamycin derivative production or sales at this time. AI, AN, and SZ are employees and\/or shareholders of the Ageless Rx, a longevity focused telemedicine platform that sponsors several clinical trials, including interventional and observational efforts for the repurposed use of rapamycin. MG is currently the senior clinical manager at the Overjet Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}